Exparel and Education to Avoid Opioids After Carpal Tunnel Release
This study is testing a new way to manage pain after carpal tunnel surgery, aiming to reduce the need for opioid pain medications. Researchers are comparing two approaches: one uses a long-lasting local anesthetic called Exparel (which works by a LIPOSOMAL mechanism) along with education about opioids. The other approach uses a standard local anesthetic (non-liposomal bupivacaine), opioid education, and opioids. The study wants to see if Exparel and education alone can effectively control pain. You might be able to join if you have carpal tunnel syndrome, are over 18, and haven't used opioids in the last six months. The main goal is to measure your pain levels after surgery using a Visual Analog Scale within the first few months. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 64 participants. It compares two different pain management strategies after carpal tunnel surgery.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your pain levels will be evaluated within the first few months of the study duration.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
At a glance
Conditions
NCT03867539
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Orthopedic Associates of Southwest Ohio
Dayton, Ohiostudy coordinator listed
Recruiting
Orthopedic Associates of Southwest Ohio
Dayton, Ohiostudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Ronald Buczek, DO · PRINCIPAL_INVESTIGATOR · Kettering Health Network
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Evaluation of post operative pain levels via Visual Analog ScaleWithin the first few months of study duration
The investigators aim to evaluate pain in either arm of the study, followed over a three day course. As several studies have shown pain to be wholly or mostly resolved by post-operative day three. Patients will answer questionnaire to include Visual Analog Scale for pain, and amount of pain medication taken. The Visual Analog Scale for pain ranges from a score of 0 to 10, with 0 being "no pain", 5 being "distressing pain", and 10 being "the worst pain imaginable"